title: [Pathophysiology, assessment and treatment of laryngopharyngeal reflux].
abstract: Laryngopharyngeal reflux is a prevalent, yet incompletely understood, ENT disorder accounting for 8 to 10% of patients consulting ENT. This clinical entity, increasingly considered as different from gastroesophageal reflux disease, may greatly affect the quality of life of patients through vocal and digestive symptoms. Debate persists concerning pathophysiology, diagnosis, and treatment. The aim of this review is to study the current literature about the pathophysiology, diagnosis, treatment, and the outcomes in the follow-up.
authors.forename: J R
authors.initials: JR
authors.lastname: Lechien
authors.forename: M
authors.initials: M
authors.lastname: Khalife
authors.forename: V
authors.initials: V
authors.lastname: Delvaux
authors.forename: K
authors.initials: K
authors.lastname: Huet
authors.forename: M
authors.initials: M
authors.lastname: Piccaluga
authors.forename: P
authors.initials: P
authors.lastname: Costa de Araujo
authors.forename: B
authors.initials: B
authors.lastname: Harmegnies
authors.forename: S
authors.initials: S
authors.lastname: Saussez
mesh_terms: D050782:Esophageal pH Monitoring / Q000379:methods; D004945:Esophagoscopy / Q000379:methods; D019317:Evidence-Based Medicine; D006356:Heartburn / Q000209:etiology; D006685:Hoarseness / Q000209:etiology; D006801:Humans; D007818:Laryngeal Diseases / Q000175:diagnosis; D057045:Laryngopharyngeal Reflux / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology* / Q000628:therapy; D007828:Laryngoscopy; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D011788:Quality of Life; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D054328:Proton Pump Inhibitors